Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Honghui Yu
Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway
PLoS ONE
Multidisciplinary
Related publications
IVIg Inhibits Reticuloendothelial System Function and Ameliorates Murine Passive-Immune Thrombocytopenia Independent of Anti-Idiotype Reactivity
British Journal of Haematology
Hematology
Autoimmunity Stimulated by Adoptively Transferred Dendritic Cells Is Initiated by Both and T Cells but Does Not Require MyD88 Signaling
Journal of Immunology
Allergy
Immunology
The Therapeutic Monoclonal Antibody Market
mAbs
Allergy
Immunology
Conversion of a Murine Monoclonal Antibody A13 Targeting Epidermal Growth Factor Receptor to a Human Monoclonal Antibody by Guided Selection
Experimental and Molecular Medicine
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Molecular Medicine
Production and Characterization of a Peptide-Based Monoclonal Antibody Against CD44 Variant 6
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
Allergy
Immunology
Immunotherapy of Hepatoma With a Monoclonal Antibody Against Murine Endoglin
World Journal of Gastroenterology
Medicine
Gastroenterology
The Word-Superiority Effect Does Not Require a T-Scope
Perception & Psychophysics
Drosophila MyD88 Is an Adapter in the Toll Signaling Pathway
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Persistent Heparin-Induced Thrombocytopenia Treated With IVIg
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
